 |
|||||
| lose weight | |||||
| NEWS | |||||
|
expert reaction to two studies looking at AstraZeneca's GLP 1 pill, elecoglipron, for reducing ...
“In adults with obesity or overweight without diabetes, elecoglipron produced dose-dependent weight loss, with average weight reductions of up to 10.5 ...
|
|||||
|
Novo Nordisk, Eli Lilly roll out obesity pills, prepare for Medicare coverage - CNBC
CEO Dave Ricks at ADA. Novo and Lilly are preparing for millions of seniors with Medicare to become eligible for GLP-1 drugs for weight loss for $50 a ...
|
|||||
|
AstraZeneca obesity pill helps patients lose 10.5% of body weight in trial | Reuters
AstraZeneca said on Monday that patients lost 10.5% of their body weight after 26 weeks in a mid-stage trial of its experimental obesity pill, ...
|
|||||
|
AstraZeneca's Obesity Pill Helps Patients Lose Weight in Midstage Trials - Morningstar
The U.K. drugmaker said Monday that the medicine, elecoglipron, resulted in 11.8% weight loss after 36 weeks of treatment in a phase 2 study in ...
|
|||||
| See more results | Edit this alert | |||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
|
Send Feedback
|
